Acta Oncologica

Papers
(The median citation count of Acta Oncologica is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000–201753
Prediction of plan adaptation in head and neck cancer proton therapy using clinical, radiographic, and dosimetric features35
Deep learning-based automatic delineation of anal cancer gross tumour volume: a multimodality comparison of CT, PET and MRI31
The first decade of the Danish Palliative Care Database: improvements and ongoing challenges in the quality and use of specialised palliative care26
A study of microRNAs as new prognostic biomarkers in anal cancer patients24
Health-Related Quality of Life in Danish Cancer Survivors Referred to a Late Effects Clinic: A Prospective Cohort Study23
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer—the first interim results from the OPTIMISE study23
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact21
Evaluation of in vitro irradiation setup: Designed for the horizontal beamline at the Danish Centre for Particle Therapy21
Use of PD-1 inhibitors in patients with end-stage renal disease: safety and clinical outcomes from real-world data21
Malignancy rates of salivary gland tumors in Greenlandic Inuit comparable to non-endemic populations; epidemiological mapping of salivary gland tumors 1990–201920
Corrigendum: Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature20
Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer – a nationwide, retrospective study19
Outcome in PCNSL patients and its association with PD-L1+ leukocytes in the tumor microenvironment18
Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac17
Adjuvant and first-line palliative chemotherapy regimens in patients diagnosed with periampullary cancer: a short report from a nationwide registry17
Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study17
Methylphenidate for treating fatigue in palliative cancer care – effect and side effects in real-world data from a palliative care unit17
Socioeconomic inequality in cancer in the Nordic countries. A systematic review16
Benefit finding, posttraumatic growth and health-related quality of life in long-term cancer survivors: a prospective population-based study16
Clinical implication of genetic intratumor heterogeneity for targeted therapy in head and neck cancer15
Influence of radiotherapy technique on incidental dose to the whole ventricular system in focal irradiation of nongerminomatous germcell tumours15
Use of 5α-reductase inhibitors and survival of oesophageal and gastric cancer in a nationwide Swedish cohort study15
The effect of tinzaparin on biomarkers in FIGO stages III-IV ovarian cancer patients undergoing neoadjuvant chemotherapy – the TABANETOC trial: study protocol for a randomized clinical multicenter tri15
Script-based automatic radiotherapy planning for cervical cancer15
Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer15
Annual surgeon and hospital volume of gastrectomy and gastric adenocarcinoma survival in a population-based cohort study15
Complications after proton radiotherapy in children, focusing on severe late complications. A complete Swedish cohort 2008–201914
Age-specific incidence, treatment, and survival trends in esophageal cancer: a Dutch population-based cohort study14
Swallowing sparing intensity modulated radiotherapy versus standard parotid sparing intensity-modulated radiotherapy for treatment of head and neck cancer: a randomized clinical trial14
Hybrid planning techniques for early-stage left-sided breast cancer: dose distribution analysis and estimation of projected secondary cancer-relative risk14
Unusual cases of sinonasal malignancies: a letter to the editor on HPV-positive sinonasal squamous cell carcinomas14
Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysis14
Socioeconomic position and the pre-diagnostic interval among patients diagnosed with head and neck squamous cell carcinoma - a population-based study from DAHANCA14
Evaluation of statin use and renal cell carcinoma risk identifies sex-specific associations with RCC subtypes14
The impact of short-course hypofractionated radiotherapy on multimodality treatment utilisation, compliance, and outcome in glioblastoma patients: a Danish patterns of care study13
Survival benefit of prophylactic cranial irradiation in limited-stage small-cell lung cancer in modern magnetic resonance imaging staging: a systematic review and meta-analysis13
Unchanged perfusion in normal-appearing white and grey matter of glioma patients nine months after proton beam irradiation13
CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research13
Influence of various assumptions for the individual TNM components on the TNM stage using Nordic cancer registry data13
Carbon-fiber alternative to the commercial gating surrogate for the Varian Truebeam™13
Evaluation of sex inequity in lung-cancer-specific survival13
Splenectomised Hodgkin lymphoma patients: does severe pneumococcal disease pose a problem today and what is the best long-term strategy?12
When breast cancer comes to the ICU: outcomes and prognostic factors12
Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma12
Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men12
Volumetric changes of the parotid gland during IMRT based on mid-treatment imaging: implications for parotid stem cell sparing strategies in head and neck cancer12
Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al.12
Mandible osteoradionecrosis after high-dose radiation therapy for head and neck cancers: risk factors and dosimetric analysis11
Desmoplastic non-infantile ganglioglioma mimicking diffuse leptomeningeal glioneuronal tumor: precision diagnostics and therapeutic implications11
Are education and cohabitation associated with health-related quality of life and self-management during breast cancer follow-up? A longitudinal study11
Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study11
The national incidence of chondrosarcoma of bone; a review11
Statin therapy and anthracycline-related cardiac dysfunction: a meta-analysis of randomized clinical trials11
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial11
Treatment-related mortality among children with cancer in Denmark during 2001-202111
The evolution of precision oncology: The ongoing impact of the Drug Rediscovery Protocol (DRUP)11
A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non–small cell lung cancer11
Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer11
Proton range uncertainty caused by synthetic computed tomography generated with deep learning from pelvic magnetic resonance imaging11
Should adjuvant radiotherapy be used in atypical meningioma (WHO grade 2) following gross total resection? A systematic review and Meta-analysis10
Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation10
Patient and public involvement in oesophageal cancer survivorship research10
Anal cancer in Sweden 2015–2019. Implementation of guidelines, structural changes, national registry and early results10
The first direct method of spot sparsity optimization for proton arc therapy10
Diffusion tensor imaging in glioblastoma patients treated with volumetric modulated arc radiotherapy: a longitudinal study10
Reduction of elective lymph node volume in radiotherapy of early anal squamous cell cancer: a comparative study between two Swedish university hospitals10
Protontherapy to maintain local control of head and neck paragangliomas10
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy10
Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer10
Factors predicting long-term physical activity of breast cancer survivors. 5-year-follow-up of the BREX exercise intervention study10
Treatment patterns, survival, and healthcare utilisation and costs in patients with locally advanced and metastatic bladder cancer in Denmark 2015–202010
Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centre9
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit9
An experimental setup for proton irradiation of a murine leg model for radiobiological studies9
Geriatric assessment and treatment outcomes in a Dutch cohort of older patients with potentially curable esophageal cancer9
Laryngeal cancer relative survival trends from 1972 to 2021 in the Nordic countries9
Psychobiological stress response to a lung cancer diagnosis: a prospective study of patients in Iceland and Sweden9
Dosimetric effects of respiratory motion during stereotactic body radiation therapy of lung tumors9
A national repository of complete radiotherapy plans: design, Results, and experiences9
Predictive value of micro-RNA expression profiling in pediatric desmoid fibromatosis9
Effect of voice rehabilitation following radiotherapy for laryngeal cancer – a 3-year follow-up of a randomised controlled trial9
Multi-center comparison between proton and photon plans for mediastinal lymphomas9
Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma9
Diet and bowel symptoms among colon cancer survivors9
Cancer in young adulthood – classifying the intensity of treatment9
Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi study9
Management and outcomes after neoadjuvant treatment for locally advanced breast cancer in older versus younger women9
Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders9
Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study8
Uncommon metachronous multiple sites recurrences of metastatic osteosarcoma cured by surgery: a case report8
Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers8
Impact of previous depression on the risk of suicide among prostate cancer patients8
Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease8
Base of tongue squamous cell carcinomas, outcome depending on treatment strategy and p16 status. A population-based study from the Swedish Head and Neck Cancer Register8
The risk of radiation-induced neurocognitive impairment and the impact of sparing the hippocampus during pediatric proton cranial irradiation8
Exercise for counteracting post-acute COVID-19 syndrome in patients with cancer: an old but gold strategy?8
Advanced cancer and concomitant dementia: access to specialized palliative care, emergency room, hospital care, and place of death8
Interventions for work participation of unemployed or work-disabled cancer survivors: a systematic review8
Impact on Health-Related quality of life after wearing compression garment or not for six months in women with mild breast cancer-related arm lymphedema. A cross-sectional study8
Physical and psychological symptom burden in patients and caregivers during follow-up care after curative surgery for cancers in the pancreas, bile ducts or duodenum8
Comparison of different 2D muscle indexes measured at the level of the 3rd lumbar vertebra in survival prediction in patients with renal cell carcinoma8
A cohort study of COVID-19 infection in pediatric oncology patients plus the utility and safety of remdesivir treatment8
Pilot implementation of MiLES: a web-based intervention targeted at managers with the aim of enhancing the successful return to work of employees with cancer8
Prevalence of mental disorders in patients with cancer compared to matched controls – secondary analysis of two nationally representative surveys8
C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients8
Changing before we have to; how to mitigate disparities in pancreatic cancer care?8
Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives7
Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors7
Patient-centered development ofEmbrace Pain: an online acceptance and commitment therapy intervention for cancer survivors with chronic painful chemotherapy-induced peripheral neuropathy7
Lung cancer registries in Denmark, Finland, Norway and Sweden: a comparison and proposal for harmonization7
Digital solution in the follow-up of early breast cancer a randomized study7
Perceived burden and need for support among caregivers of cancer patients7
5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy7
FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study7
Prospective randomised phase II trial evaluating adjuvant pelvic radiotherapy using either IMRT or 3-Dimensional planning for endometrial cancer7
Experimental validation of a novel method of dose accumulation for the rectum7
The ultimate local failure rate after the watch-and-wait strategy for rectal cancer: a systematic review of literature and meta-analysis7
Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characterist7
Acute normal tissue responses in a murine model following fractionated irradiation of the head and neck with protons or X-rays7
Classification of laterality and mastectomy/lumpectomy for breast cancer patients for improved performance of deep learning auto segmentation7
Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer7
Impact of the COVID-19 pandemic on number and stages of tumors – data of a German cancer registry7
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy7
Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer7
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials7
Commentary to ‘Incidence of vestibular schwannoma in Finland, 1990–2017’ Pediatric vestibular schwannomas: an overlooked epidemiological aspect?7
Cancer in the Faroe Islands from 1960-2019 – incidence, mortality, and comparisons with the other Nordic countries7
Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors7
Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study6
Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study6
Reply to Assoc. Prof. Kocak6
Early intervention with compression garments prevents progression in mild breast cancer-related arm lymphedema: a randomized controlled trial6
The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis6
Sexual functioning, sexual enjoyment, and body image in Norwegian breast cancer survivors: a 12-year longitudinal follow-up study and comparison with the general female population6
Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemotherapy6
High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation6
Multimodal prehabilitation in elective oncological colorectal surgery enhances preoperative physical fitness: a single center prospective real-world data analysis6
The iBLAD app protocol – a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care6
Sexually transmitted diseases in cancer patients diagnosed under the age of 20 years – a national registry-based cohort study from Finland6
Geriatric impairments are prevalent and predictive of survival in older patients with cancer receiving radiotherapy: a prospective observational study6
Hot dots – which nodes should be removed in sentinel lymph node biopsy for melanoma?6
Impact of comorbidity on renal cell carcinoma prognosis: a nationwide cohort study6
Cluster model incorporating heterogeneous dose distribution of partial parotid irradiation for radiotherapy induced xerostomia prediction with machine learning methods6
Patient-reported lower limb edema after primary radiotherapy for prostate cancer6
Societal costs of ovarian cancer in a population-based cohort – a cost of illness analysis6
Referral patterns of GIST patients: data from a nationwide study6
The influence of radiation dose on taste impairment in a prospective observational study cohort of oropharyngeal cancer patients6
Electron beam radiotherapy for the management of squamous cell carcinoma of the anal margin6
Progress against lung cancer, Denmark, 2008–20226
The booster dose of BNT162b2 mRNA vaccine in patients after hematopoietic stem cell transplantation: humoral and clinical response and serological conversion predictors6
Outcomes of fractionated CyberKnife radiosurgery in patients with choroidal malignant melanoma6
Drop in cancer diagnosis during the COVID-19 pandemic in Denmark: assessment of impact during 20206
The impact of baseline health factors on second primary cancer risk after radiotherapy for prostate cancer6
Association of patient-reported pain with survival in bladder cancer: a post-hoc analysis of the iBLAD trial6
Diagnosis and treatment of breast cancer in Denmark during the COVID-19 pandemic: a nationwide population-based study6
Familial features affecting the melanoma risk in CDKN2A -negative melanoma families: a study based on the Swedish Cancer Registry5
Long-term resource utilisation and associated costs of exercise during (neo)adjuvant oncological treatment: the Phys-Can project5
Somatostatin receptor expression in Merkel cell carcinoma: correlation with clinical data5
Reduction in myocardial function and oxygen consumption after chemoradiotherapy in patients with esophageal cancer5
Consistency in contouring of organs at risk by artificial intelligence vs oncologists in head and neck cancer patients5
Predictive factors for prolonged sick leave in breast cancer patients treated with adjuvant therapies: a retrospective registry study5
Turning the page on 2024 – embracing Open Science5
High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings5
Increased use of computed tomography in Denmark: stage shift toward early stage lung cancer through incidental findings5
The effect of psychosocial interventions for sexual health in patients with pelvic cancer: a systematic review and meta-analysis5
Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland5
Changes in experienced quality of oncological cancer care during the COVID-19 pandemic based on patient reported outcomes – a cross-sectional study5
Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis5
Clinical outcomes of ALK + non-small cell lung cancer in Denmark5
Risk factors for seroma formation after axillary lymph node dissection with special focus on the impact of early shoulder exercise5
Diagnosis of locally recurrent head and neck squamous cell carcinoma in the Nordic HNC centers and feasibility of the Odense-Birmingham definition5
Cervical, liver and stomach cancer incidence and mortality in non-Western immigrant women: a retrospective cohort study from four Nordic countries5
No time to die– BiGART is back. The 20th Acta Oncologica Symposium – BIGART 20215
Oligoscore: a clinical score to predict overall survival in patients with oligometastatic disease treated with stereotactic body radiotherapy5
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms5
Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy5
Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia5
Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab5
Transitioning from conventional photon therapy to proton therapy for primary brain tumors5
Correction5
Multi-disciplinary team meetings for lung cancer in Norway and Denmark: results from national surveys and observations with MDT-MODe5
Comparing Iridium-192 with Cobalt-60 sources in high-dose-rate brachytherapy boost for localized prostate cancer5
Correction5
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer5
A novel report of nivolumab-induced transient and persistent acantholytic dermatosis associated with multiple cutaneous toxicities in a patient with metastatic melanoma5
Effectiveness of physiotherapy interventions on improving quality of life, total neuropathy score, strength and reducing pain in cancer survivors suffering from chemotherapy-induced peripheral neuropa5
Recent incidence trends of oesophago-gastric cancer in Sweden5
A comparative analysis of fear of cancer recurrence in patients with small renal masses: Active surveillance versus cryoablation5
Clinical implications of dose to functional lung volumes in the trimodality treatment of esophageal cancer5
Primary splenic angiosarcoma: a case series of a rare oncological entity and diagnostic challenge5
Increased cancer incidence among patients with hidradenitis suppurativa – a Danish nationwide register study 1977–20175
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors5
177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer5
Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study4
Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular disease4
Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study4
Temporal trends in lung cancer survival: a population-based study4
Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer – the MetAction precision medicine study4
The association between education and fear of recurrence among breast cancer patients in follow-up – and the mediating effect of self-efficacy4
The influence of metabolic factors and ethnicity on breast cancer risk, treatment and survival: The Oslo ethnic breast cancer study4
Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre study4
Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature4
Correction4
Treatment-related mortality in childhood cancer patients – who, when and how much4
Who are the vulnerable lung cancer patients at risk for not receiving first-line curative or palliative treatment?4
Area-based disparities in non-small-cell lung cancer survival4
Blood sampling patterns in primary care change several years before a cancer diagnosis4
Patterns of care in oligometastatic disease: the clinicians’ perspective4
Trends in treatment of non-small cell lung cancer in Finland 2014–20194
Health-related quality of life, needs, and concerns among cancer survivors referred to rehabilitation in primary healthcare setting4
Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration – a Swedish nationwide retrospective study4
Differences in adjuvant chemotherapy and oncological outcomes according to margin status in patients with stage III colon cancer4
Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial4
Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients4
Interim analysis of patient-reported outcome compliance and dosimetry in a phase 3 randomized clinical trial of oesophagus-sparing spinal radiotherapy4
Implementing MyChoice® CDx HRD testing for the Nordics: lessons from 2021 to 20234
Trends in cost of treatment of lung cancer patients in 2014–2019 in Finland – a descriptive register study4
Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study4
Involving adolescents and young adults (AYA) with an uncertain or poor cancer prognosis as research partners4
Age and prognosis in patients with pancreatic cancer: a population-based study4
Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer4
Real-life experience with sorafenib for advanced and refractory desmoid-type fibromatosis4
Survival after palliative radiotherapy in nondisseminated nonsmall cell lung cancer treated with 30 Gy in 10 fractions or 39 Gy in 13 fractions using conformal technique4
Radiation-induced prostate swelling during SBRT of the prostate4
Circulating DNA in the neoadjuvant setting of early stage colon cancer4
Improving knowledge-based treatment planning for lung cancer radiotherapy with automatic multi-criteria optimized training plans4
Real-world survival of Danish patients with HER2-positive metastatic breast cancer4
Does the ypTNM-stage adequately predict long-term survival rates in gastric cancer patients receiving neoadjuvant chemotherapy followed by radical resection?4
Spot-scanning proton therapy for early breast cancer in free breathing versus deep inspiration breath-hold4
Electrochemotherapy for metastatic cutaneous melanoma4
Long-term survival after treatment for primary anal cancer– results from the Swedish national ANCA cohort study4
Dosimetric comparison between proton beam therapy, intensity modulated radiation therapy, and 3D conformal therapy for soft tissue extremity sarcoma4
Cost-effectiveness of different exercise intensities during oncological treatment in the Phys-Can RCT4
Parenting under pressure: a cross-sectional questionnaire study of psychological distress, parenting concerns, self-efficacy, and emotion regulation in parents with cancer4
Second primary cancer following primary oral squamous cell carcinoma: a population-based, retrospective study4
Prospective evaluation of bowel function and quality of life after colon cancer surgery – is it time for routine screening for late sequelae?4
The gold standard program (GSP) for smoking cessation: a cohort study of its effectiveness among smokers with and without cancer4
Survival with lung cancer in Finland has not improved during 2007–2019–a single center retrospective population-based real-world study4
End-of-life care of patients with esophageal or gastric cancer: decision making and the goal of care4
Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival – a Swedish Lymphoma Register Study4
The BioLymph study – implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results4
Is it okay to choose to receive bad news by telephone? An observational study on psychosocial consequences of diagnostic workup for lung cancer suspicion4
Combination therapy with immune check point inhibitors and acute kidney injury4
Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide4
Predictors of preparedness for recovery following colorectal cancer surgery: a latent class trajectory analysis4
Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study4
Significant risk of second primary cancer among laryngeal squamous cell carcinoma patients even after 20 years4
Robustness of multifield pseudo-arc proton therapy for sinonasal cancer4
Comprehensive analysis of matrix metalloproteinases and their inhibitors in head and neck squamous cell carcinoma4
0.206130027771